<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39326119</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-3573</ISSN><JournalIssue CitedMedium="Internet"><Volume>281</Volume><PubDate><Year>2025</Year><Month>Jan</Month><Day>01</Day></PubDate></JournalIssue><Title>Talanta</Title><ISOAbbreviation>Talanta</ISOAbbreviation></Journal><ArticleTitle>Enhanced performance of impedimetric immunosensors to detect SARS-CoV-2 with bare gold nanoparticles and graphene acetic acid.</ArticleTitle><Pagination><StartPage>126903</StartPage><MedlinePgn>126903</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.talanta.2024.126903</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0039-9140(24)01282-7</ELocationID><Abstract><AbstractText>Immunosensors based on electrical impedance spectroscopy allow for label-free, real-time detection of biologically relevant molecules and pathogens, without requiring electro-active materials. Here, we investigate the influence of bare gold nanoparticles (AuNPs), synthesized via laser ablation in solution, on the performance of an impedimetric immunosensor for detecting severe acute respiratory syndrome coronavirus (SARS-CoV-2). Graphene acetic acid (GAA) was used in the active layer for immobilizing anti-SARS-CoV-2 antibodies, owing to its high density of carboxylic groups. Immunosensors incorporating AuNPs exhibited superior performance compared to those relying solely on GAA, achieving a limit of detection (LoD) of 3 x 10<sup>-20</sup> g/mL to detect the Spike Receptor Binding Domain (RBD) protein of SARS-CoV-2 and of 2 PFU/mL for inactivated virus. Moreover, these immunosensors presented high selectivity against the H1N1 influenza virus. We anticipate that this platform will be versatile and applicable in the early diagnosis of various diseases and viral infections, thereby facilitating Point-of-Care testing.</AbstractText><CopyrightInformation>Copyright © 2024. Published by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hensel</LastName><ForeName>Rafael C</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Sao Carlos Institute of Physics, University of Sao Paulo, Sao Carlos, Brazil. Electronic address: hensel@ifsc.usp.br.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Vizio</LastName><ForeName>Biagio</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Chemical Sciences, University of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Materòn</LastName><ForeName>Elsa M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Sao Carlos Institute of Physics, University of Sao Paulo, Sao Carlos, Brazil; Sao Carlos Institute of Chemistry, University of Sao Paulo, São Carlos, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shimizu</LastName><ForeName>Flávio M</ForeName><Initials>FM</Initials><AffiliationInfo><Affiliation>Institute of Physics Gleb Wataghin, University of Campinas, Campinas, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Angelim</LastName><ForeName>Monara Kaelle S C</ForeName><Initials>MKSC</Initials><AffiliationInfo><Affiliation>Laboratory of Immunometabolism, Department of Genetics, Evolution, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Souza</LastName><ForeName>Gabriela F</ForeName><Initials>GF</Initials><AffiliationInfo><Affiliation>Department of Genetics, Evolution, Microbiology and Immunology, Institute of Biology - University of Campinas, Campinas, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Módena</LastName><ForeName>José L P</ForeName><Initials>JLP</Initials><AffiliationInfo><Affiliation>Department of Genetics, Evolution, Microbiology and Immunology, Institute of Biology - University of Campinas, Campinas, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moraes-Vieira</LastName><ForeName>Pedro M M</ForeName><Initials>PMM</Initials><AffiliationInfo><Affiliation>Laboratory of Immunometabolism, Department of Genetics, Evolution, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Azevedo</LastName><ForeName>Ricardo B</ForeName><Initials>RB</Initials><AffiliationInfo><Affiliation>Institute of Biological Sciences, University of Brasilia, Brasilia, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Litti</LastName><ForeName>Lucio</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Chemical Sciences, University of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agnoli</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Chemical Sciences, University of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casalini</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Chemical Sciences, University of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliveira</LastName><ForeName>Osvaldo N</ForeName><Initials>ON</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Sao Carlos Institute of Physics, University of Sao Paulo, Sao Carlos, Brazil. Electronic address: chu@ifsc.usp.br.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Talanta</MedlineTA><NlmUniqueID>2984816R</NlmUniqueID><ISSNLinking>0039-9140</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>7440-57-5</RegistryNumber><NameOfSubstance UI="D006046">Gold</NameOfSubstance></Chemical><Chemical><RegistryNumber>7782-42-5</RegistryNumber><NameOfSubstance UI="D006108">Graphite</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D055910">Antibodies, Immobilized</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>Q40Q9N063P</RegistryNumber><NameOfSubstance UI="D019342">Acetic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006046" MajorTopicYN="Y">Gold</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053768" MajorTopicYN="Y">Metal Nanoparticles</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006108" MajorTopicYN="Y">Graphite</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007118" MajorTopicYN="N">Immunoassay</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057230" MajorTopicYN="Y">Limit of Detection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015374" MajorTopicYN="N">Biosensing Techniques</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058266" MajorTopicYN="N">Dielectric Spectroscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055910" MajorTopicYN="N">Antibodies, Immobilized</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019342" MajorTopicYN="N">Acetic Acid</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Gold nanoparticles</Keyword><Keyword MajorTopicYN="N">Graphene acetic acid</Keyword><Keyword MajorTopicYN="N">Immunosensors</Keyword><Keyword MajorTopicYN="N">Impedance spectroscopy</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Osvaldo Novais de Oliveira Jr. reports financial support was provided by Coordination of Higher Education Personnel Improvement (CAPES). Osvaldo Novais de Oliveira Jr. reports financial support was provided by National Council for Scientific and Technological Development (CNPq). Osvaldo Novais de Oliveira Jr. reports financial support was provided by State of Sao Paulo Research Foundation (FAPESP). Rafael Cintra Hensel reports financial support was provided by State of Sao Paulo Research Foundation. Stefano Casalini reports financial support was provided by Nanochemistry for Energy and Health. Stefano Casalini reports financial support was provided by Nexus. Stefano Casalini reports financial support was provided by Complessità Chimica C2. Stefano Casalini reports financial support was provided by Government of Italy Commission for the Selection of Excellence University Departments. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>26</Day><Hour>18</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39326119</ArticleId><ArticleId IdType="doi">10.1016/j.talanta.2024.126903</ArticleId><ArticleId IdType="pii">S0039-9140(24)01282-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle>